DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 127 filers reported holding DIPLOMAT PHARMACY INC in Q2 2015. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $5,571,000 | +3.8% | 1,392,674 | +27.1% | 0.00% | 0.0% |
| Q3 2019 | $5,368,000 | +3.0% | 1,095,429 | +28.0% | 0.00% | 0.0% |
| Q2 2019 | $5,214,000 | +36.4% | 856,069 | +30.2% | 0.00% | +50.0% |
| Q1 2019 | $3,822,000 | -48.3% | 657,754 | +19.8% | 0.00% | -66.7% |
| Q4 2018 | $7,393,000 | -27.7% | 549,223 | +4.2% | 0.01% | -14.3% |
| Q3 2018 | $10,229,000 | -9.5% | 526,977 | +19.1% | 0.01% | -12.5% |
| Q2 2018 | $11,307,000 | +43.8% | 442,349 | +13.3% | 0.01% | +33.3% |
| Q1 2018 | $7,865,000 | +11.4% | 390,276 | +11.0% | 0.01% | 0.0% |
| Q4 2017 | $7,057,000 | +15.7% | 351,592 | +19.4% | 0.01% | +20.0% |
| Q3 2017 | $6,100,000 | +79.1% | 294,497 | +28.0% | 0.01% | +66.7% |
| Q2 2017 | $3,405,000 | +30.3% | 230,013 | +40.4% | 0.00% | 0.0% |
| Q1 2017 | $2,613,000 | +33.6% | 163,769 | +5.5% | 0.00% | +50.0% |
| Q4 2016 | $1,956,000 | -57.2% | 155,219 | -4.9% | 0.00% | -60.0% |
| Q3 2016 | $4,572,000 | +1.8% | 163,194 | +27.3% | 0.01% | -16.7% |
| Q2 2016 | $4,489,000 | +45.8% | 128,231 | +14.2% | 0.01% | +50.0% |
| Q1 2016 | $3,078,000 | -18.5% | 112,335 | +1.8% | 0.00% | -20.0% |
| Q4 2015 | $3,778,000 | +17.1% | 110,397 | -1.7% | 0.01% | 0.0% |
| Q3 2015 | $3,227,000 | -33.7% | 112,303 | +3.2% | 0.01% | -28.6% |
| Q2 2015 | $4,870,000 | +307.9% | 108,816 | +215.3% | 0.01% | +250.0% |
| Q1 2015 | $1,194,000 | +32.1% | 34,514 | +4.6% | 0.00% | +100.0% |
| Q4 2014 | $904,000 | – | 33,006 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|